A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

NCT03554798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1025

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: nOPV2 (monovalent oral polio vaccine)

Sponsor

Fidec Corporation

Collaborators

[object Object]